Evidence map›Paper›PMID 24345944›Full record

ArticleNature chemistry2014

The aromatic ene reaction.

Dawen Niu, Thomas R Hoye

Abstract read
In one paragraph

Article in Nature chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Article
  3. Organic letters · 2021
    Article
  4. Review
  5. Article
  6. Enantiomeric Separation of New Chiral Azole Compounds.Molecules (Basel, Switzerland) · 2021
    Article
  7. Article
  8. Reactions of HDDA Benzynes withEuropean journal of organic chemistry · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Analyzing Reaction Rates with the Distortion/Interaction-Activation Strain Model.Angewandte Chemie (International ed. in English) · 2017
    Review
  15. Photochemical Hexadehydro-Diels-Alder Reaction.Journal of the American Chemical Society · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dawen NiuDepartment of Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, USA.
Thomas R HoyeDepartment of Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, USA.

Funding

SYNTHESIS OF ANTITUMOR AGENTSR01CA076497 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HOYE, THOMAS R. · 1998 to 2014
$3.5M
Synthesis Strategies for Bioactive Natural ProductsR01GM065597 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HOYE, THOMAS R. · 2002 to 2016
$3.1M
NCI NIH HHS CA76497NCI NIH HHS R01 CA076497NIGMS NIH HHS GM65597NIGMS NIH HHS R01 GM065597
6 · The paper itself

Abstract

The ene reaction is a pericyclic process in which an alkene with an allylic hydrogen atom (the ene donor) reacts with a second unsaturated species (the enophile) to form a new product with a transposed π-bond. The aromatic ene reaction, in which the alkene component is embedded in an aromatic ring, has only been reported in a few (four) instances and has proceeded in low yield (≤6%). Here, we show efficient aromatic ene reactions in which a thermally generated aryne intermediate engages a pendant m-alkylarene substituent to produce a dearomatized isotoluene, itself another versatile but rare reactive intermediate. Our experiments were guided by computational studies that revealed structural features conducive to the aromatic ene process. We proceeded to identify a cascade comprising three reactions: (1) hexadehydro-Diels-Alder (for aryne generation), (2) intramolecular aromatic ene and (3) bimolecular Alder ene. The power of this cascade is evident from the structural complexity of the final products, the considerable scope, and the overall efficiency of these multistage, reagent- and by-product-free, single-pot transformations.

Indexed as

AlkenesHydrogen BondingAlkenes

Identifiers

PMID24345944
PMCPMC4281267

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.